An Analysis of Cost-Effectiveness and Clinical Outcomes of a Comprehensive Aortic Service in a Tertiary Center over One Year

被引:0
|
作者
Songra, Lalana A. K. [1 ]
Baker, Daryll M. [1 ,2 ,4 ]
Agu, Obiekezie [1 ]
Constantinou, Jason [1 ]
Hynes, Niamh [3 ]
机构
[1] Royal Free Hosp NHS Fdn Trust, Dept Vasc Surg, London, England
[2] UCL, UCL Div Med, Royal Free Campus, London, England
[3] Natl Univ Ireland Galway, SFI Res Ctr Med Devices, CURAM, Biomed Sci, Galway, Ireland
[4] UCL, Div Med, UCL Royal Free Campus,Pond St, London NW3 2QG, England
关键词
OPEN SURGICAL REPAIR; ENDOVASCULAR REPAIR; ANEURYSMS; EVAR; SURGERY; TRIALS;
D O I
10.1016/j.avsg.2023.09.084
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Endovascular aortic repair (EVAR) is an established and attractive alternative to open surgical repair (OSR) of abdominal aortic aneurysms (AAA) due to its superior short-term safety profile. However, opinions are divided regarding its long-term cost-effectiveness. We compared the total yearly cost of running endovascular and OSR services in a single tertiary center to determine whether fenestrated EVAR (FEVAR) represents a clinically efficacious, affordable treatment option.Methods: A single-center retrospective review was performed on 109 patients undergoing a procedure related to index or previous abdominal aortic repair, with 1 year follow-up. Data was collected from the National Vascular Registry and hospital records. The primary outcome was cost per quality-adjusted life year. Secondary outcomes included 30-day mortality and morbidity, reintervention rates, length of hospital stay, aneurysm, and all-cause mortality at 1 year for elective index procedures.Results: The average cost per patient of all FEVAR was 16,041.53 pound (+/- 8,857.54), 13,893.51 pound (+/-21,425.25) pound for standard EVAR, and 15,357.22 pound (+/-15,904.49) pound for OSR (FEVAR versus EVAR P = 0.55, FEVAR versus OSR P = 0.83, OSR versus EVAR P = 0.76). Of the secondary outcomes, significant findings included increased length of stay and respiratory morbidity for patients undergoing open versus endovascular repair. There was no significant difference in 30 -day or 1-year mortality between groups.Conclusions: FEVAR, EVAR, and OSR all represent cost-effective options for aortic repair with similar outcomes. Our data highlights the potential for FEVAR to present a viable alternative to open repair, particularly in higher-risk groups, when performed in specialist centers.
引用
收藏
页码:125 / 134
页数:10
相关论文
共 50 条
  • [21] Clinical outcomes and cost-effectiveness of initial treatment strategies for nonembolic acute limb ischemia in real-life clinical settings
    Lurie, Fedor
    Vaidya, Varun
    Comerota, Anthony J.
    JOURNAL OF VASCULAR SURGERY, 2015, 61 (01) : 138 - 146
  • [22] Cost-effectiveness analysis of transcatheter aortic valve implantation in aortic stenosis patients at low- and intermediate-surgical risk in Japan
    Kobayashi, Junjiro
    Baron, Suzanne J.
    Takagi, Kensuke
    Thompson, Christin A.
    Jiao, Xiayu
    Yamabe, Kaoru
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 697 - 707
  • [23] Robotic versus laparoscopic distal pancreatectomy: a French prospective single-center experience and cost-effectiveness analysis
    Souche, Regis
    Herrero, Astrid
    Bourel, Guillaume
    Chauvat, John
    Pirlet, Isabelle
    Guillon, Francoise
    Nocca, David
    Borie, Frederic
    Mercier, Gregoire
    Fabre, Jean-Michel
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (08): : 3562 - 3569
  • [24] Cost-effectiveness analysis of robotic-assisted versus retropubic radical prostatectomy: a single cancer center experience
    de Oliveira, Renato Almeida Rosa
    Guimaraes, Gustavo Cardoso
    Mourao, Thiago Camelo
    de Lima Favaretto, Ricardo
    Santana, Thiago Borges Marques
    Lopes, Ademar
    de Cassio Zequi, Stenio
    JOURNAL OF ROBOTIC SURGERY, 2021, 15 (06) : 859 - 868
  • [25] Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period
    Scaldaferri, F.
    Papa, A.
    Napolitano, D.
    Rizzatti, G.
    Pistone, M. T.
    Poscia, A.
    Volpe, M.
    Lopetuso, L. R.
    Schiavoni, E.
    Guidi, L.
    Gaetani, E.
    Holleran, G.
    Cammarota, G.
    Rapaccini, G.
    Pugliese, D.
    Ojetti, V
    Franceschi, F.
    Armuzzi, A.
    Gasbarrini, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5826 - 5835
  • [26] One-year cost-effectiveness and safety of simultaneous hybrid coronary revascularization versus conventional coronary artery bypass grafting
    Rimestad, Jesper Moller
    Christiansen, Evald Hoj
    Modrau, Ivy Susanne
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 29 (02) : 217 - 223
  • [27] Effect of Lockdown and Unlock Following COVID-19 on the Presentation of Patients With Endophthalmitis at a Tertiary Eye Center Over One Year
    Das, Anthony Vipin
    Dave, Vivek Pravin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [28] Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: a cost-effectiveness analysis in Belgium
    Dubois, Christophe
    Adriaenssens, Tom
    Annemans, Lieven
    Bosmans, Johan
    Callebaut, Britt
    Candolfi, Pascal
    Cornelis, Kristoff
    Delbaere, Alexis
    Green, Michelle
    Kefer, Joelle
    Lancellotti, Patrizio
    Rosseel, Michael
    Shore, Judith
    Van Der Heyden, Jan
    Vermeersch, Sebastian
    Wyffels, Eric
    ACTA CARDIOLOGICA, 2024, 79 (01) : 46 - 57
  • [29] Clinical trial outcomes and thoracic aortic morphometry after one year with the Valiant Navion stent graft system
    Verzini, Fabio
    Desai, Nimesh
    Arko, Frank R.
    Panneton, Jean M.
    Thaveau, Fabien
    Dagenais, Francois
    Guo, Jia
    Azizzadeh, Ali
    JOURNAL OF VASCULAR SURGERY, 2021, 74 (02) : 569 - +
  • [30] A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis: a cost-effectiveness analysis
    McBain, Hayley
    Flood, Chris
    Shipley, Michael
    Olaleye, Abigail
    Moore, Samantha
    Newman, Stanton
    RHEUMATOLOGY, 2021, 60 (01) : 277 - 287